Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2021-10-01 00:00:00 ET · period of report 2021-09-29 · accession 0001209191-21-058606 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-01 | 2021-10-01 | MIRM | Longpre Lara | Chief Development Off | S - Sale | $19.26 | -961 | 84.2K | -1% | -$18.5K | |
| 2021-10-01 | 2021-09-29 | MIRM | Longpre Lara | Chief Development Off | A - Grant | $0.00 | +8,125 | 85.2K | +11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-01 | S | D | 961 | $19.26 | 84,245 | D | — | — | (F2) Shares sold to cover tax withholding obligations associated with the vesting of the performance-based restricted stock unit award granted to the Reporting Person on March 9, 2021. |
| 2 | Common | Common Stock | 2021-09-29 | A | A | 8,125 | $0.00 | 85,206 | D | — | — | (F1) The shares became issuable upon the satisfaction of certain performance conditions that were established at the time of the Compensation Committee's approval of a performance-based restricted stock unit award on March 9, 2021. On September 29, 2021, the Compensation Committee certified the achievement of the performance criteria resulting in the vesting of 4,062 shares on September 29, 2021 and 4,063 shares on June 30, 2023. |